Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. News
  7. Sector news
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
Delayed Japan Exchange  -  01:00:00 2023-02-02 am EST
7935.00 JPY   -1.05%
01/31Eisai-Biogen Gets Priority Review for Alzheimer's Drug in Japan
MT
01/30Global markets live: Toyota, Unilever, Bayer, Goldman Sachs, Biogen...
MS
01/30It's all about central banks this week
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
02:14aRoche 2022 Sales Grew, But Expects 2023 Decline on Covid-19 Products -- Update
DJ
02:02aRoche flags 2023 earnings decline on slump in COVID products
RE
01:47aRoche 2022 Sales Grew, But Expects 2023 Decline on Covid-19 Products
DJ
01:29aRoche's FY22 Profit Falls as COVID-19 Boost Fades
MT
12:47aFormycon Licenses Stelara Biosimilar Candidate to Fresenius Unit
MT
02/01Merck & Co. Says No Direct Evidence of COVID-19 Pill Leading to New Variants
MT
02/01Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap...
MS
02/01Trending: Novartis's 4Q Net Profit Declines on Poor Drug Performances
DJ
02/01Novo Nordisk Q4 Earnings, Sales Rise; Issues 2023 Outlook; to Start 28 Billion Kroner S..
MT
02/01NOVO NORDISK : Jefferies gives a Sell rating
MD
02/01Transcript : Novo Nordisk A/S, 2022 Earnings Call, Feb 01, 2023
CI
02/01NOVO NORDISK : Sell rating from UBS
MD
02/01NOVO NORDISK : JP Morgan maintains a Buy rating
MD
02/01Scancell Holdings Names Jean-Michel Cossery Nonexecutive Chairman
DJ
02/01European shares gain on pharma boost; Fed policy decision on tap
RE
02/01Novo Nordisk Launches $4 Billion Buyback as 4Q Earnings Beat Forecasts
DJ
02/01Novo Nordisk to Launch New DKK28 Billion Share Repurchase Program
MT
02/01Novo Nordisk Reports 16% Jump in FY22 Net Profit on Double-Digit Sales Growth
MT
02/01Novartis Lifts Dividend Despite 4Q Sales, Profit Decline
DJ
02/01European Commission Expands Marketing Permit for Roche's Hemlibra
MT
01/31Amgen revenue falls slightly as Lilly COVID deal contributes less
RE
01/31Moody's Says Johnson & Johnson's Court Loss is Negative Credit Development
MT
01/31Global markets live: GM, Pfizer, Exxon, UBS, Boeing...
MS
01/31UBS Adjusts Eli Lilly and Company Price Target to $406 From $420, Maintains Buy Rating
MT
01/31UBS Adjusts Merck & Company Price Target to $108 From $105, Maintains Neutral Rating
MT
01/31Idorsia Files European Marketing Authorization Application For Resistant Hypertension T..
MT
01/31PrescriberPoint, Inc. announced that it has received funding from Eli Lilly and Company..
CI
01/31Carsgen Therapeutics Holdings Limited Announces Collaboration Agreement with F. Hoffman..
CI
01/30Roche's Diagnostics Division Joins Jana Care on Remote Blood Testing Platform
MT
01/30Sector Update: Health Care Stocks' Losses Gain Speed Near Monday Close
MT
01/30Sector Update: Health Care
MT
01/30Johnson & Johnson Worst Performer in the DJIA So Far Today -- Data Talk
DJ
01/30Top Midday Decliners
MT
01/30Jana Care, Inc. to Enter Collaboration with Roche Diagnostics to Develop and Distribute..
CI
01/30Mega-Cap Tech Earnings on Tap; Fed's Policy Leanings Cool US Equity Investors' Risk App..
MT
01/30Drugmakers prevail in dispute over U.S. discount drug program
RE
01/30AstraZeneca Doses First Patient in Phase 3 Study of Datopotamab Deruxtecan to Treat Lun..
MT
01/30Johnson & Johnson's Bankruptcy Petition for Talc Unit Dismissed by Court; Shares Down M..
MT
01/30Johnson & Johnson Stock Falls Amid Reports US Appeals Court Rejected Company's Use of B..
MT
01/30Johnson & Johnson Talc Bankruptcy Case Thrown Out b..
MT
01/30Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment
AN
01/30European Equities Start the Week Modestly Higher Amid German GDP Contraction
MT
01/30Berenberg Bank Adjusts Merck & Company Price Target to $125 From $115, Maintains Buy Ra..
MT
01/30Berenberg Lowers Price Target on Roche, Maintains Buy Recommendation
MT
01/30ROCHE HOLDINGS AG : Berenberg reiterates its Buy rating
MD
01/27Eli Lilly's Oncology Unit Gets US FDA's Approval for Mantle Cell Lymphoma Drug
MT
01/27FDA Approves Eli Lilly's Jaypirca to Treat Lymphoma Patients
DJ
01/27Eli Lilly Receives US FDA's Nod of Jaypirca to Treat Mantle Cell Lymphoma
MT
01/27Eli Lilly and Company Announces That the U.S. Food and Drug Administration Approved Jay..
CI
01/27Johnson & Johnson's Janssen Says Carvykti Meets Target in Late-Stage Blood Cancer Trial
MT
01/27Eli Lilly's Diabetes Drug Recommended for Approval by European Medicines Agency Committ..
MT
01/27Johnson & Johnson Unit Withdraws European Application for Imbruvica Drug Combination to..
MT
01/27Merck Says Keytruda Approved by FDA as Adjuvant Treatment for Non-Small Cell Lung Cance..
MT
01/27Merck Announces the U.S. Food and Drug Administration has Approved KEYTRUDA
CI
01/26Merck & Co.'s Animal Health Unit Wins US FDA Nod for Expanded Use of Flea Drug for Dogs
MT
01/26Sector Update: Healthcare Stocks Climb Back to Finish Higher
MT
01/26Merck Animal Health Division Says US FDA Approves Expanded Indication of Bravecto Chews..
MT
01/26Eli Lilly Earmarks $1 Million to Boost Cold Chain Capacity in 17 Countries
MT
01/26Sector Update: Health Care Stocks Advance Pre-Bell Thursday
MT
01/26Evotec, Johnson & Johnson's Janssen Biotech Enter Cancer Drug Development Collaboration
MT
01/26Evotec Shares Climb After Agreement With Janssen on Immunotherapies Development
DJ
01/26Evotec Starts Oncology-development Collaboration With Johnson & Johnson Unit
MT
01/26Roche Develops New COVID-19 PCR Test for Omicron Subvariant XBB.1.5
MT
01/26Roche launches new test to detect fast spreading Omicron sub-variant
RE
01/26Roche Launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-Varia..
CI
01/25Merck & Co.'s Keytruda Combo Prolongs Survival in Late-stage Biliary Tract Cancer Study
MT
01/25Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From $176, Maintains E..
MT
01/25Roche, Sysnav to Develop Outcome Measurements for Movement Impairment Ailments
MT
01/25NOVO NORDISK : Buy rating from JP Morgan
MD
01/25Atlantic Equities Adjusts Johnson & Johnson's Price Target to $168 From $160, Keeps Neu..
MT
01/25Novo Nordisk Signs New License Agreement with Howwe Technologies
MT
01/25Merck to Cease Phase 3 Trial for Treatment of Prostate Cancer Due to Failure in Meeting..
MT
01/25Merck Reports Keytruda Phase 3 Success, Failure
DJ
01/25Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA« (pembrolizumab) Plus Enzalutamid..
CI
01/25Merck’s KEYTRUDA« (pembrolizumab) Plus Chemotherapy Significantly Improved Overall..
CI
01/25NOVO NORDISK : Receives a Buy rating from Goldman Sachs
MD
01/25ROCHE HOLDINGS AG : Barclays reaffirms its Buy rating
MD
01/25NOVO NORDISK : Barclays keeps its Buy rating
MD
01/25Sysnav Healthcare Announces A Multi-Year Collaboration with Roche Based on Sysnav's Pro..
CI
01/25RLS Global Chairman to Depart in February; Successor Nominated
MT
01/24Sector Update: Health Care Stocks Still Sagging Near Close
MT
01/24Merck & Company Keeps Quarterly Dividend at $0.73 a Share; Payable April 10 to Holders ..
MT
01/24Surprise Manufacturing Gain Leaves Equities Mixed
MT
01/24Sector Update: Health Care Stocks Retreating on Tuesday
MT
01/24Sector Update: Health Care
MT
01/24Merck Announces Dividend for the Second-Quarter of 2023 , Payable on April 10, 2023
CI
01/24Technology Heavyweights Earnings Kick-Start, Unexpected Improvement in Manufacturing In..
MT
01/24Johnson & Johnson on Track for Longest Losing Streak Since August 1981 -- Data Talk
DJ
01/24Johnson &Johnson CFO on Earnings Forecast, Costs, and Consumer Spinoff
MT
01/24Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton...
MS
01/24Sector Update: Health Care Stocks Flat to Lower Pre-Bell Tuesday
MT
01/24Prospect of Further Federal Reserve Interest Rate Increases Pressuring Exchange-Traded ..
MT
01/24Johnson & Johnson Fourth-Quarter Revenue Falls on Lower COVID-19 Vaccine Sales; Guides ..
MT
01/24Transcript : Johnson & Johnson, Q4 2022 Earnings Call, Jan 24, 2023
CI
01/24FTSE 100 down as UK PMIs raise recession fears
AN
01/24Eli Lilly to Allocate Another $450 Million Toward Manufacturing Capacity Expansion at N..
MT
01/24Johnson & Johnson Q4 Adjusted Profit Rises; Sales Drop; Full-Year 2023 Guidance Release..
MT
01/24Eli Lilly Plans $450 Million Investment To Expand US Manufacturing Site
MT
01/24Eli Lilly and Company Plans to Invest Additional $450 Million At Manufacturing Site in ..
CI
01/24Earnings Flash (JNJ) JOHNSON & JOHNSON Reports Q4 Revenue $23.71B, vs. Street Est of $2..
MT
Upcoming event on EISAI CO., LTD.